He Huang

Qionghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Topical 1.5% ruxolitinib cream for facial refractory segmental vitiligo: A retrospective single-center study.

Topical 1.5% ruxolitinib cream for facial refractory segmental vitiligo: A retrospective single-center study.

Journal: JAAD international

Published: November 17, 2025

Clinical efficacy and safety analysis of 1.5% ruxolitinib cream in the treatment of facial vitiligo in adolescents: A retrospective study of 74 cases.

Clinical efficacy and safety analysis of 1.5% ruxolitinib cream in the treatment of facial vitiligo in adolescents: A retrospective study of 74 cases.

Journal: Journal of the American Academy of Dermatology

Published: November 15, 2025

Targeted synergy for vitiligo in refractory areas: A real-world study of ruxolitinib cream combined with 308-nm excimer lamp.

Targeted synergy for vitiligo in refractory areas: A real-world study of ruxolitinib cream combined with 308-nm excimer lamp.

Journal: Journal of the American Academy of Dermatology

Published: November 05, 2025

Beyond depigmentation: A cross-sectional study of 5227 Chinese patients with vitiligo.

Beyond depigmentation: A cross-sectional study of 5227 Chinese patients with vitiligo.

Journal: The Journal of investigative dermatology

Published: August 19, 2025

Topical ruxolitinib ± oral baricitinib in the treatment of active non-segmental vitiligo: A retrospective analysis.

Topical ruxolitinib ± oral baricitinib in the treatment of active non-segmental vitiligo: A retrospective analysis.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: August 17, 2025

Efficacy and safety of oral upadacitinib-topical ruxolitinib combination therapy in the treatment of progressive nonsegmental vitiligo.

Efficacy and safety of oral upadacitinib-topical ruxolitinib combination therapy in the treatment of progressive nonsegmental vitiligo.

Journal: JAAD international

Published: July 21, 2025

Efficacy of ruxolitinib cream at different body sites in Chinese patients with nonsegmental vitiligo.

Efficacy of ruxolitinib cream at different body sites in Chinese patients with nonsegmental vitiligo.

Journal: Journal of the American Academy of Dermatology

Published: May 21, 2025

Correlation Between the Koebner Phenomenon and Clinical Features in Vitiligo.

Correlation Between the Koebner Phenomenon and Clinical Features in Vitiligo.

Journal: Clinical, cosmetic and investigational dermatology

Published: November 14, 2024

Effectiveness and safety of ruxolitinib cream in Chinese patients with nonsegmental vitiligo.

Effectiveness and safety of ruxolitinib cream in Chinese patients with nonsegmental vitiligo.

Journal: Journal of the American Academy of Dermatology

Published: October 29, 2024

Efficacy and safety of secukinumab in Chinese patients with psoriasis: Update of six-year real-world data and a meta-analysis.

Efficacy and safety of secukinumab in Chinese patients with psoriasis: Update of six-year real-world data and a meta-analysis.

Journal: Chinese medical journal

Published: October 24, 2024

Transcriptome and Chromatin Landscape Changes Associated with Pathogenesis of Psoriasis in Memory T Helper and Memory Regulatory T Cells.

Transcriptome and Chromatin Landscape Changes Associated with Pathogenesis of Psoriasis in Memory T Helper and Memory Regulatory T Cells.

Journal: The Journal of investigative dermatology

Published: October 11, 2024

Multitranscriptome analysis reveals stromal cells in the papillary dermis to promote angiogenesis in psoriasis vulgaris.

Multitranscriptome analysis reveals stromal cells in the papillary dermis to promote angiogenesis in psoriasis vulgaris.

Journal: The British journal of dermatology

Published: July 02, 2024

Showing 1-12 of 33

Last Updated: 09/26/2026